中东和非洲疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗(仿制药、原创药、疫苗等)、给药途径(口服和肠外给药)和分销渠道(直接招标、医院药房、零售药房、网上药房等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 120    |    Report Code: TIPRE00025041    |    Category: Life Sciences

Middle East & Africa Malaria Treatment Market
2022 年,中东和非洲疟疾治疗市场价值为 20.9128 亿美元,预计到 2030 年将达到 155.1297 亿美元;预计 2022 年至 2030 年的复合年增长率为 28.5%。

新药和疫苗的不断涌现推动中东和非洲疟疾治疗市场的发展

抗菌素耐药性会使公众面临多种疾病的风险,例如疟疾。为了克服这一挑战,新药的研发被认为是最佳策略;因此,抗疟药物研发渠道正变得越来越强大。公私合作伙伴关系正在加速与疟疾治疗相关的研究活动。例如,非营利组织“疟疾药物研发基金会”(MMV)与众多制药公司合作,通过开发新的治疗方案来减轻疟疾负担。因此,越来越多的抗疟药和处于临床开发的药物/疫苗预计将在未来推动市场增长。

下表列出了一些正在进行临床开发的抗疟药物:

表 1. 正在进行临床开发的抗疟药物/疫苗/化合物

药物开发商临床试验阶段

Artefenomel 赛诺菲 IIb 期

KAE609 诺华公司 IIb 期

KAF156 诺华公司 IIb 期

DSM265 武田制药公司 IIa 期

SANARIA PfSPZ-GA1 Sanaria II 期

SANARIA PfSPZ 疫苗 - 辐射减毒 PfSPZ 疫苗 Sanaria II 期

SANARIA PfSPZ-CVac Sanaria II 期

MSP3-CRM-Vac4All Vac4All I 期

肝阶段抗原 3 (LSA3) Vac4All IIa 期

来源:公司网站,Insight Partners 分析

因此,抗疟和正在临床开发的药物/疫苗有望在未来推动市场增长。

中东和非洲疟疾治疗市场概览

中东和非洲其他地区的疟疾治疗市场分为以色列、伊朗、伊拉克、科威特、阿曼、埃及、卡塔尔等。《地中海血液学和传染病杂志》报告指出,输入性疟疾对卡塔尔构成了严重的健康问题。例如,尽管卡塔尔的输入性疟疾一直在减少,但在过去七年中却有所增加,受影响最严重的是来自疟疾流行国家的成年男性移民。此外,非政府组织已介入,在疟疾流行的国家提供健康教育和预防工具。此外,联邦政府还投资制作商业广告,教育公众了解疟疾的传播以及保护和治疗方法,这可能会促进中东和非洲其他地区的疟疾治疗市场。

中东和非洲疟疾治疗市场收入及预测至 2030 年(百万美元)

中东和非洲疟疾治疗市场细分

中东和非洲疟疾治疗市场根据治疗、给药途径、分销渠道和国家进行细分。根据治疗,中东和非洲疟疾治疗市场细分为仿制药、原研药、疫苗和其他。疫苗部分在 2022 年占据最大市场份额。

就给药途径而言,中东和非洲疟疾治疗市场分为口服和肠外给药。口服部分在 2022 年占据了更大的市场份额。

按分销渠道,中东和非洲疟疾治疗市场细分为直接招标、医院药房、零售药房、网上药房和其他。 2022 年,直接招标部分占据了最大的市场份额。

根据国家/地区,中东和非洲疟疾治疗市场细分为南非、沙特阿拉伯、阿联酋、肯尼亚、坦桑尼亚、卢旺达、尼日利亚、加纳、乌干达、安哥拉、喀麦隆、塞内加尔、赞比亚和中东和非洲其他地区。2022 年,中东和非洲其他地区占据了中东和非洲疟疾治疗市场份额的主导地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc 和 Lupin Ltd 是中东和非洲疟疾治疗市场的一些领先参与者。

Middle East & Africa Malaria Treatment Strategic Insights

Strategic insights for Middle East & Africa Malaria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-malaria-treatment-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 2,091.28 Million
Market Size by 2030 US$ 15,512.97 Million
Global CAGR (2022 - 2030) 28.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 治疗
  • 仿制药
  • 原创药物
  • 疫苗
By 给药途径
  • 口服
  • 肠胃外
By 分销渠道
  • 直接招标
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Get more information on this report

    Middle East & Africa Malaria Treatment Regional Insights

    The regional scope of Middle East & Africa Malaria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-malaria-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Malaria Treatment Market

    1. Cipla Ltd
    2. Sun Pharmaceutical Industries Ltd
    3. Sanofi SA
    4. GSK Plc
    5. Novartis AG
    6. Pfizer Inc
    7. Lupin Ltd

    Frequently Asked Questions
    How big is the Middle East & Africa Malaria Treatment Market?

    The Middle East & Africa Malaria Treatment Market is valued at US$ 2,091.28 Million in 2022, it is projected to reach US$ 15,512.97 Million by 2030.

    What is the CAGR for Middle East & Africa Malaria Treatment Market by (2022 - 2030)?

    As per our report Middle East & Africa Malaria Treatment Market, the market size is valued at US$ 2,091.28 Million in 2022, projecting it to reach US$ 15,512.97 Million by 2030. This translates to a CAGR of approximately 28.5% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Malaria Treatment Market report typically cover these key segments-

  • 治疗 (仿制药, 原创药物, 疫苗)
  • 给药途径 (口服, 肠胃外)
  • 分销渠道 (直接招标, 医院药房, 零售药房, 网上药房)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Malaria Treatment Market?

    The Middle East & Africa Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Who should buy this report?

    The Middle East & Africa Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.